Our data agree with previous reports in which C-MYC activities are down-modulated in pancreatic CSC [4], while Noh and colleagues showed enrichment of stem-cell phenotypes in human cervical cancer cells by NANOG upregulation [39]. This evidence concerns the gene MYC and cervical cancer.